NSIS B logo

Novozymes A/S Stock Price

CPSE:NSIS B Community·DKK 196.6b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 32 Fair Values set on narratives written by author

NSIS B Share Price Performance

DKK 422.20
20.70 (5.16%)
DKK 471.06
Fair Value
DKK 422.20
20.70 (5.16%)
10.4% undervalued intrinsic discount
DKK 471.06
Fair Value
Price DKK 422.20
AnalystConsensusTarget DKK 471.06
AnalystLowTarget DKK 380.00
AnalystHighTarget DKK 560.00

NSIS B Community Narratives

AnalystConsensusTarget·
Fair Value DKK 471.06 10.4% undervalued intrinsic discount

Enzyme Biosolutions And Preventive Health Trends Will Drive Long-Term Expansion

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AnalystLowTarget·
Fair Value DKK 380 11.1% overvalued intrinsic discount

Bioenergy And Biosolutions Demand Will Support Earnings Despite Regulatory And Competitive Headwinds

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AnalystHighTarget·
Fair Value DKK 560 24.6% undervalued intrinsic discount

Emerging Markets And Biofuels Will Support A Stronger Long Term Outlook

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
DKK 380
11.1% overvalued intrinsic discount
Revenue
6.12% p.a.
Profit Margin
19.32%
Future PE
35.9x
Price in 2028
DKK 447.87
DKK 471.06
10.4% undervalued intrinsic discount
Revenue
6.83% p.a.
Profit Margin
18.91%
Future PE
44.56x
Price in 2028
DKK 555.11

Trending Discussion

Updated Narratives

NSIS B logo

Emerging Markets And Biofuels Will Support A Stronger Long Term Outlook

Fair Value: DKK 560 24.6% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
NSIS B logo

Bioenergy And Biosolutions Demand Will Support Earnings Despite Regulatory And Competitive Headwinds

Fair Value: DKK 380 11.1% overvalued intrinsic discount
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
NSIS B logo

Enzyme Biosolutions And Preventive Health Trends Will Drive Long-Term Expansion

Fair Value: DKK 471.06 10.4% undervalued intrinsic discount
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Excellent balance sheet with proven track record and pays a dividend.

2 Risks
2 Rewards

Novozymes A/S Key Details

€4.1b

Revenue

€1.7b

Cost of Revenue

€2.4b

Gross Profit

€1.9b

Other Expenses

€547.0m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Feb 25, 2026
1.17
58.55%
13.20%
28.9%
View Full Analysis

About NSIS B

Founded
1925
Employees
10582
CEO
Ester Baiget
WebsiteView website
www.novonesis.com

Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as protein solutions and early lie nutrition. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services. In addition, the company provides dishwashing, softener, and microbial and medical cleaning services. Further, it offers corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; warm water species, recirculating aquaculture system; animal health and nutrition solutions; and fiber modification, bleach boosting, deposit control, and starch modification solutions. Additionally, the company provides carbon capture, leather and textiles solutions; enzyme solutions, including corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; warm water species and recirculating aquaculture system solutions; human health solutions comprising brain, oral, protective and immune, and gastrointestinal health solutions; ethanol, biodiesel, renewable diesel, wastewater, sewage, and renewable diesel solutions; and agriculture and industry, biogas food waste, food waste, biocatalysis, cell culture, enzyme, and biogas solutions. It also provides lipases, proteases, oxidoreductases, and carbohydrases. Novozymes A/S was founded in 1925 and is based in Lyngby, Denmark.

Recent NSIS B News & Updates

Recent updates

No updates

Novozymes A/S Competitors